Przejdź do zawartości
Merck
Wszystkie zdjęcia(1)

Key Documents

MABF3038

Sigma-Aldrich

Anti-Rhinovirus Capsid VP1 Antibody, clone HRV-18003

Synonim(y):

HRV-capsid VP1

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych


About This Item

Kod UNSPSC:
12352203
NACRES:
NA.41

pochodzenie biologiczne

mouse

Poziom jakości

forma przeciwciała

purified antibody

rodzaj przeciwciała

primary antibodies

klon

HRV-18003, monoclonal

masa cząsteczkowa

calculated mol wt 242.824 kDa
observed mol wt ~32 kDa

oczyszczone przez

using protein G

reaktywność gatunkowa

virus

opakowanie

antibody small pack of 100

metody

ELISA: suitable
inhibition assay: suitable
western blot: suitable

izotyp

IgG2aκ

sekwencja epitopowa

N-terminal half

numer dostępu Protein ID

numer dostępu UniProt

temp. przechowywania

-10 to -25°C

Specyficzność

Clone HRV-18003 is a mouse monoclonal antibody that detects Rhinovirus. It targets an epitope within 8 amino acids from the N-terminal half.

Immunogen

DNA encoding P1-2A and 3C of different strains of Rhinoviruses in pCAGGS plasmids.

Zastosowanie

Quality Control Testing

Evaluated by Western Blotting with recombinant Rhinovirus Capsid VP1 protein.

Western Blotting Analysis: A 1:125 dilution of this antibody detected recombinant Rhinovirus Capsid VP1 protein.

Tested Applications

Functional Assay A representative lot of this antibody exhibited strong activity in in vitro antibody dependent cellular phagocytosis (ADCP) assay. (Behzadi, M.A., et al. (2020). Sci Rep.;10(1):9750).

Western Blotting Analysis: A representative lot detected HRV-18003 recognizes VP1 in Western Blotting applications (Behzadi, M.A., et al. (2020). Sci Rep.;10(1):9750).

ELISA Analysis: A representative lot detected HRV-18003 recognizes VP1 in ELISA applications (Behzadi, M.A., et al. (2020). Sci Rep.;10(1):9750).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Opis wartości docelowych

Rhinoviruses (RV) belong to the Picornavirus family and are known as a leading cause of respiratory infections. Over 160 different types of rhinoviruses have been identified and based on their genetic diversity and phylogenetic sequence analysis they are grouped as rhinovirus A, B, and C. Three different membrane glycoproteins are known to serve as receptors for these viruses. ICAM-1 is used by a majority of A group and all B group rhinoviruses, a small number of group A viruses use the low-density lipoprotein receptor (LDLR), and the group C of rhinoviruses use cadherin-related family member 3 receptor (CDKR3). Canyons on the surface of the virus are known to provide an attachment site for receptors on the surface of susceptible target cells. Viral infectivity is neutralized when host immunoglobulin G binds to the surface of the virus, thereby blocking interaction between the host cell receptor and the receptor binding site located at the base of the canyon. The RV is composed of single-stranded RNA within a capsid with icosahedral symmetry. The viral capsid of human RV is comprised of four viral proteins: VP1, VP2, VP3, and VP4. The remaining viral proteins are responsible for viral replication and subsequent assembly. Capsid protein VP1 forms an icosahedral capsid of pseudo-T=3 symmetry with capsid proteins VP2 and VP3. VP1 interacts with host cell receptor to provide virion attachment to target host cells. This attachment induces virion internalization. VP1 is the most exposed surface protein and plays a critical role in viral antigenicity and induction of neutralizing antibodies. Clone HRV-18003 binds to a conserve epitope within VP1 and displays cross reactivity with multiple types of rhinoviruses, including A1A, A1B, A15, and A49. It exhibits strong antibody dependent cellular phagocytosis (ADCP) against A1A and A16 viruses. (Ref.: Behzadi, MA., et al. (2020). Sci. Rep. 10(1):9750; Basnet, S., et al. (2019). Chest. ;155(5):1018-1025).

Postać fizyczna

Purified mouse monoclonal antibody IgG2a in PBS without preservatives.

Rekonstytucja

0.5 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Przechowywanie i stabilność

Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

Inne uwagi

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Oświadczenie o zrzeczeniu się odpowiedzialności

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
This page may contain text that has been machine translated.

Nie możesz znaleźć właściwego produktu?  

Wypróbuj nasz Narzędzie selektora produktów.

Kod klasy składowania

12 - Non Combustible Liquids

Klasa zagrożenia wodnego (WGK)

WGK 2

Temperatura zapłonu (°F)

Not applicable

Temperatura zapłonu (°C)

Not applicable


Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej